CA2716514A1 — Hiv protease inhibitor and cytochrome p450 inhibitor combinations
Assigned to Sequoia Pharmaceuticals Inc · Expires 2009-08-27 · 17y expired
What this patent protects
Compositions and methods of treating viral infections are provided. More particularly, compositions including a combina-tion of protease inhibitors and cytochrome p450 enzyme inhibitors are provided. Methods of using the compositions for treatment of diseases or disorders caused …
USPTO Abstract
Compositions and methods of treating viral infections are provided. More particularly, compositions including a combina-tion of protease inhibitors and cytochrome p450 enzyme inhibitors are provided. Methods of using the compositions for treatment of diseases or disorders caused by a virus such as HIV infections are also provided.
Drugs covered by this patent
- Copiktra (DUVELISIB) · Secura
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.